IBDEI0ZQ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16799,1,3,0)
 ;;=3^Gout, unspec
 ;;^UTILITY(U,$J,358.3,16799,1,4,0)
 ;;=4^M10.9
 ;;^UTILITY(U,$J,358.3,16799,2)
 ;;=^5010404
 ;;^UTILITY(U,$J,358.3,16800,0)
 ;;=K21.9^^70^791^1
 ;;^UTILITY(U,$J,358.3,16800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16800,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,16800,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,16800,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,16801,0)
 ;;=R31.0^^70^791^9
 ;;^UTILITY(U,$J,358.3,16801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16801,1,3,0)
 ;;=3^Gross Hematuria
 ;;^UTILITY(U,$J,358.3,16801,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,16801,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,16802,0)
 ;;=B02.9^^70^792^22
 ;;^UTILITY(U,$J,358.3,16802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16802,1,3,0)
 ;;=3^Herpes (Zoster) w/o complications
 ;;^UTILITY(U,$J,358.3,16802,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,16802,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,16803,0)
 ;;=B19.10^^70^792^18
 ;;^UTILITY(U,$J,358.3,16803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16803,1,3,0)
 ;;=3^Hepatitis B,Viral Unspec
 ;;^UTILITY(U,$J,358.3,16803,1,4,0)
 ;;=4^B19.10
 ;;^UTILITY(U,$J,358.3,16803,2)
 ;;=^5000552
 ;;^UTILITY(U,$J,358.3,16804,0)
 ;;=B17.10^^70^792^2
 ;;^UTILITY(U,$J,358.3,16804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16804,1,3,0)
 ;;=3^Acute Hepatitis C w/o hepatic coma
 ;;^UTILITY(U,$J,358.3,16804,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,16804,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,16805,0)
 ;;=B18.2^^70^792^21
 ;;^UTILITY(U,$J,358.3,16805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16805,1,3,0)
 ;;=3^Hepatitis C,Viral,Chronic
 ;;^UTILITY(U,$J,358.3,16805,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,16805,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,16806,0)
 ;;=E05.90^^70^792^28
 ;;^UTILITY(U,$J,358.3,16806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16806,1,3,0)
 ;;=3^Hyperthyroidism w/o Thyrotoxic Crisis/Storm,Unspec
 ;;^UTILITY(U,$J,358.3,16806,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,16806,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,16807,0)
 ;;=E03.9^^70^792^34
 ;;^UTILITY(U,$J,358.3,16807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16807,1,3,0)
 ;;=3^Hypothyroidism, unspec
 ;;^UTILITY(U,$J,358.3,16807,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,16807,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,16808,0)
 ;;=E16.2^^70^792^31
 ;;^UTILITY(U,$J,358.3,16808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16808,1,3,0)
 ;;=3^Hypoglycemia, unspec
 ;;^UTILITY(U,$J,358.3,16808,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,16808,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,16809,0)
 ;;=E78.0^^70^792^24
 ;;^UTILITY(U,$J,358.3,16809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16809,1,3,0)
 ;;=3^Hypercholesterolemia,Pure
 ;;^UTILITY(U,$J,358.3,16809,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,16809,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,16810,0)
 ;;=E78.0^^70^792^29
 ;;^UTILITY(U,$J,358.3,16810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16810,1,3,0)
 ;;=3^Hypertriglyceridemia
 ;;^UTILITY(U,$J,358.3,16810,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,16810,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,16811,0)
 ;;=E78.5^^70^792^26
 ;;^UTILITY(U,$J,358.3,16811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16811,1,3,0)
 ;;=3^Hyperlipidemia, unspec
 ;;^UTILITY(U,$J,358.3,16811,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,16811,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,16812,0)
 ;;=E87.1^^70^792^30
 ;;^UTILITY(U,$J,358.3,16812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16812,1,3,0)
 ;;=3^Hypo-osmolality and hyponatremia
 ;;^UTILITY(U,$J,358.3,16812,1,4,0)
 ;;=4^E87.1
